FF on NYSE
Logo: futurefuelcorporation.com5
FutureFuel Corporation is a developer and producer of chemicals and biofuels.3 From Wikipedia, CC BY-SA 4.0
Price unavailable
Last updated Oct 19, 2026.
Compare with Codexis, Gevo, Inc or LanzaTech Global, Inc., or pick any stock.
See how the biggest companies compare on our leaderboards
FutureFuel Corporation is a developer and producer of chemicals and biofuels. It is listed on the New York Stock Exchange, with symbol FF.3
From the company’s reports to the SEC. Every number links to the filing it came from.
Revenue by product, business segment and region, as the company reports it to the SEC.
Chemicals brought in 62% of the revenue FutureFuel broke down this way in fiscal 2025.
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Chemicals | $79.3M | $80.0M | $59.6M |
| Biofuels | $288.9M | $163.3M | $36.2M |
United States brought in 99% of the revenue FutureFuel broke down this way in fiscal 2025.
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| United States | $367.4M | $242.7M | $94.8M |
| Outside the United States | $882.0K | $654.0K | $952.0K |
Out of $95.7M in revenue.8 The company lost money this year.
Every line of the income statement as filed: the last 3 fiscal years, latest first.8
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | $95.7M | $243.3M | $368.2M |
| Gross (loss) profit | -$39.4M | $19.6M | $41.0M |
| Compensation expense | $5.6M | $4.8M | $4.5M |
| Other expense | $3.5M | $3.8M | $4.1M |
| Related party expense | $674.0K | $632.0K | $616.0K |
| Research and development expenses | $3.9M | $4.0M | $4.4M |
| Total operating expenses | $13.6M | $13.3M | $13.6M |
| (Loss) income from operations | -$53.0M | $6.4M | $27.4M |
| Interest and dividend income | $3.9M | $7.7M | $9.6M |
| Interest expense | -$153.0K | -$138.0K | -$138.0K |
| Gain on marketable securities | $0 | $0 | $575.0K |
| Other income, net | $0 | $2.4M | $1.0K |
| Other income | $3.8M | $9.9M | $10.0M |
| (Loss) income before income taxes | -$49.2M | $16.3M | $37.4M |
| Income tax provision | $165.0K | $792.0K | $1.0K |
| Basic (in dollars per share) | -$1.13 | $0.35 | $0.85 |
| Diluted (in dollars per share) | -$1.13 | $0.35 | $0.85 |
| Basic (in shares) | 43.9M shares | 43.8M shares | 43.8M shares |
| Diluted (in shares) | 43.9M shares | 43.8M shares | 43.8M shares |
| Net (loss) income | -$49.4M | $15.5M | $37.4M |
| Other comprehensive income (loss) from unrealized net losses on available-for- sale debt securities | $0 | $0 | $2.0K |
| Income tax effect | $0 | $0 | -$1.0K |
| Total unrealized gain (loss), net of tax | $0 | $0 | $1.0K |
| Comprehensive (loss) income | -$49.4M | $15.5M | $37.4M |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.8
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $51.3M | $109.5M | ||
| Accounts receivable, inclusive of the blenders tax credit of $0 and $6,683, and net of allowances for credit losses of $28 and $29, respectively | $9.4M | $21.9M | ||
| Inventory, net | $21.3M | $20.6M | ||
| Income tax receivable | $88.0K | $53.0K | ||
| Other current assets | $14.4M | $8.7M | ||
| Total current assets | $100.5M | $164.8M | ||
| Property, plant and equipment, net | $86.8M | $78.5M | ||
| Other noncurrent assets | $4.9M | $4.4M | ||
| Total noncurrent assets | $91.7M | $82.9M | ||
| Total Assets | $192.2M | $247.7M | ||
| Deferred revenue current | $1.7M | $904.0K | ||
| Dividends payable-current | $2.8M | $10.7M | ||
| Accrued expenses and other current liabilities | $2.6M | $11.1M | ||
| Total current liabilities | $17.7M | $33.3M | ||
| Deferred revenue noncurrent | $14.5M | $6.3M | ||
| Dividends payable -noncurrent | $196.0K | $0 | ||
| Noncurrent deferred income taxes | $910.0K | $773.0K | ||
| Other noncurrent liabilities | $4.2M | $1.5M | ||
| Total noncurrent liabilities | $19.8M | $8.6M | ||
| Total liabilities | $37.5M | $41.9M | ||
| Preferred stock | $0 | $0 | ||
| Common stock, $0.0001 par value, 75,000,000 shares authorized, 43,863,507 and 43,803,243 issued and outstanding as of December 31, 2025 and 2024, respectively | $4.0K | $4.0K | ||
| Additional paid in capital | $203.8M | $205.4M | ||
| Retained earnings (accumulated deficit) | -$49.1M | $383.0K | ||
| Total stockholders equity | $154.7M | $205.8M | $309.9M | $283.0M |
| Total Liabilities and Stockholders Equity | $192.2M | $247.7M | ||
| Allowance for bad debt | $28.0K | $29.0K | ||
| Accounts receivable, tax credits | $0 | $6.7M | $11.4M | |
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized (in shares) | 5.0M shares | 5.0M shares | ||
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Common stock, shares authorized (in shares) | 75.0M shares | 75.0M shares | ||
| Common stock, shares issued (in shares) | 43.9M shares | 43.8M shares | ||
| Common stock, shares outstanding (in shares) | 43.9M shares | 43.8M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $51.3M | $109.5M | ||
| Accounts receivable, inclusive of the blenders tax credit of $0 and $6,683, and net of allowances for credit losses of $28 and $29, respectively | $9.4M | $21.9M | ||
| Inventory, net | $21.3M | $20.6M | ||
| Income tax receivable | $88.0K | $53.0K | ||
| Other current assets | $14.4M | $8.7M | ||
| Total current assets | $100.5M | $164.8M | ||
| Property, plant and equipment, net | $86.8M | $78.5M | ||
| Other noncurrent assets | $4.9M | $4.4M | ||
| Total noncurrent assets | $91.7M | $82.9M | ||
| Total Assets | $192.2M | $247.7M | ||
| Deferred revenue current | $1.7M | $904.0K | ||
| Dividends payable-current | $2.8M | $10.7M | ||
| Accrued expenses and other current liabilities | $2.6M | $11.1M | ||
| Total current liabilities | $17.7M | $33.3M | ||
| Deferred revenue noncurrent | $14.5M | $6.3M | ||
| Dividends payable -noncurrent | $196.0K | $0 | ||
| Noncurrent deferred income taxes | $910.0K | $773.0K | ||
| Other noncurrent liabilities | $4.2M | $1.5M | ||
| Total noncurrent liabilities | $19.8M | $8.6M | ||
| Total liabilities | $37.5M | $41.9M | ||
| Preferred stock | $0 | $0 | ||
| Common stock, $0.0001 par value, 75,000,000 shares authorized, 43,863,507 and 43,803,243 issued and outstanding as of December 31, 2025 and 2024, respectively | $4.0K | $4.0K | ||
| Additional paid in capital | $203.8M | $205.4M | ||
| Retained earnings (accumulated deficit) | -$49.1M | $383.0K | ||
| Total stockholders equity | $154.7M | $205.8M | $309.9M | $283.0M |
| Total Liabilities and Stockholders Equity | $192.2M | $247.7M | ||
| Allowance for bad debt | $28.0K | $29.0K | ||
| Accounts receivable, tax credits | $0 | $6.7M | $11.4M | |
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized (in shares) | 5.0M shares | 5.0M shares | ||
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Common stock, shares authorized (in shares) | 75.0M shares | 75.0M shares | ||
| Common stock, shares issued (in shares) | 43.9M shares | 43.8M shares | ||
| Common stock, shares outstanding (in shares) | 43.9M shares | 43.8M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.8
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net (loss) income | -$49.4M | $15.5M | $37.4M |
| Depreciation | $9.7M | $9.2M | $10.3M |
| Amortization of deferred financing costs | $82.0K | $103.0K | $101.0K |
| (Benefit) provision for deferred income taxes | $137.0K | $773.0K | $0 |
| Change in fair value of equity securities | $0 | $0 | -$3.1M |
| Change in fair value of derivative instruments | -$221.0K | $2.0M | -$1.9M |
| Loss on the sale of investments | $0 | $0 | $2.5M |
| Stock based compensation | $1.0M | $359.0K | $0 |
| (Gain) loss on disposal of property, plant, and equipment | -$34.0K | $30.0K | $29.0K |
| Noncash interest expense | $36.0K | $35.0K | $34.0K |
| Accounts receivable | $12.5M | $6.5M | -$2.2M |
| Accounts receivable related parties | $0 | $1.0K | $5.0K |
| Inventory | -$611.0K | $4.7M | -$4.4M |
| Income tax receivable | -$35.0K | $1.9M | $19.0K |
| Prepaid expenses | -$99.0K | $380.0K | -$652.0K |
| Other assets | -$4.4M | -$146.0K | -$935.0K |
| Accounts payable | -$519.0K | -$12.1M | -$6.5M |
| Accounts payable related parties | -$99.0K | $97.0K | -$7.8M |
| Dividends payable | $47.0K | $186.0K | $0 |
| Accrued expenses and other current liabilities | -$8.5M | $6.3M | -$720.0K |
| Deferred revenue | $9.0M | -$9.2M | -$2.4M |
| Other noncurrent liabilities | $2.7M | -$1.9M | $1.5M |
| Net cash (used in) provided by operating activities | -$28.7M | $24.8M | $21.3M |
| Collateralization of derivative instruments | -$1.4M | -$132.0K | $1.3M |
| Proceeds from the sale of marketable securities | $0 | $0 | $37.7M |
| Proceeds from the sale of property, plant, and equipment | $34.0K | $6.0K | $0 |
| Capital expenditures | -$17.2M | -$14.7M | -$6.0M |
| Net cash (used in) provided by investing activities | -$18.6M | -$14.8M | $33.0M |
| Deferred financing costs | -$376.0K | $0 | -$14.0K |
| Payment of dividends | -$10.5M | -$119.9M | -$10.5M |
| Net cash used in financing activities | -$10.9M | -$119.9M | -$10.5M |
| Net change in cash and cash equivalents | -$58.2M | -$109.9M | $43.8M |
| Cash paid for interest | $71.0K | $0 | $0 |
| Cash paid for income taxes | $27.0K | $457.0K | $20.0K |
| Noncash capital expenditures included in accounts payable | $669.0K | $403.0K | $333.0K |
| Dividends payable | $3.0M | $10.7M | $10.5M |
No quarter-by-quarter statement was filed.
In 2005 the company was founded in Clayton, Missouri as Viceroy Acquisition Corp., a Special-purpose acquisition company. In 2006 Viceroy acquired a plant in Batesville, Arkansas from Eastman Chemical and subsequently changed its name to FutureFuel. Lee Mikles was CEO from 2006 until 2013. Since 2013 Tony Novelly has been chairman and CEO.
From Wikipedia’s article on FutureFuel, shared under CC BY-SA 4.0.7
Who has led FutureFuel, and when. Pick a name to see everywhere that person has worked.
The company operates in two segments: chemicals and biofuels.
The company has a wholly owned subsidiary named FutureFuel Chemical Company, which develops various chemical products selling to third party customers. The chemical segment consists of two components, which are custom manufacturing that produce chemicals for specific customers, and performance multi-customer specialty chemicals. During 2011, about 50% of the company's revenue came from manufacturing specialty chemicals.
The biofuel segment mainly produce biodiesel, as well as petrodiesel. This operation segment is in central Arkansas, where the company owns 2,200 acres of land six miles southeast of Batesville, Arkansas.
From Wikipedia’s article on FutureFuel, shared under CC BY-SA 4.0.7
184 filings to the SEC since October 2021: 6 annual reports, 17 quarterly reports, 78 major events, 59 insider forms, 15 large holders, 9 other. The latest 20:
The 184 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
18 open-market trades by officers, directors and large owners since October 2021: 17 buys and 1 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Polet RoelandChief Executive Officer | Buy | 10,000 | $4.28 | $42.8K | Form 4 |
| Nov 20, 2025 | Polet RoelandChief Executive Officer | Buy | 15,000 | $3.20 | $48.0K | Form 4 |
| Apr 3, 2025 | Rowe Richard P.Director | Buy | 15,000 | $3.95 | $59.2K | Form 4 |
| Apr 3, 2025 | Rowe Richard P.Director | Buy | 15,000 | $3.95 | $59.2K | Form 4 |
| Apr 3, 2025 | Bedell Donald C.Director | Buy | 10,000 | $4.00 | $40.0K | Form 4 |
| Nov 15, 2024 | Bedell Donald C.Director | Buy | 10,000 | $5.10 | $51.0K | Form 4 |
| Nov 13, 2024 | Polet RoelandChief Executive Officer | Buy | 10,000 | $5.11 | $51.1K | Form 4 |
| Aug 15, 2024 | Manheim PaulDirector | Buy | 6,000 | $6.10 | $36.6K | Form 4 |
| Jun 13, 2024 | KRUSZEWSKI RONALD JDirector | Buy | 50,358 | $4.60 | $231.6K | Form 4 |
| Jun 12, 2024 | KRUSZEWSKI RONALD JDirector | Buy | 41,098 | $4.57 | $187.8K | Form 4 |
| Jun 11, 2024 | KRUSZEWSKI RONALD JDirector | Buy | 8,544 | $4.50 | $38.4K | Form 4 |
| Jun 6, 2024 | Lyon Charles W.Chief Commercial Officer | Buy | 11,400 | $4.36 | $49.7K | Form 4 |
| Jun 4, 2024 | EGGER TERRANCE C ZDirector | Buy | 5,000 | $4.39 | $21.9K | Form 4 |
| Jun 3, 2024 | Bedell Donald C.Director | Buy | 2,025 | $4.15 | $8.4K | Form 4 |
| Jun 3, 2024 | Thomas McKinlayChief Executive Officer | Buy | 20,000 | $4.38 | $87.6K | Form 4 |
| Jun 3, 2024 | SPARKS ROSEChief Financial Officer | Buy | 5,000 | $4.35 | $21.8K | Form 4 |
| Dec 8, 2022 | Bedell Donald C.Director | Sale | 9,000 | $9.00 | $81.0K | Form 4 |
| Oct 29, 2021 | Bedell Donald C.Director | Buy | 5,000 | $7.15 | $35.8K | Form 4 |
From Forms 4 filed with the SEC.
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 1,914,410 | $8.7M | 0.0% | +82,521 |
| Renaissance Technologies LLC | 1,433,400 | $6.5M | 0.0% | −144,300 |
| Dimensional Fund Advisors LP | 1,431,611 | $6.5M | 0.0% | −258,493 |
| Ameriprise Financial Inc | 1,315,729 | $5.9M | 0.0% | +1,208,276 |
| Vanguard Capital Management LLC | 1,141,243 | $5.2M | 0.0% | −24,229 |
| Two Sigma Investments, LP | 782,079 | $3.5M | 0.0% | −45,996 |
| Geode Capital Management, LLC | 660,893 | $3.0M | 0.0% | −1,730 |
| State Street Corp | 620,421 | $2.8M | 0.0% | −915 |
| Citadel Advisors LLC | 540,985 | $2.4M | 0.0% | +154,337 |
| Bridgeway Capital Management, LLC | 473,285 | $2.1M | 0.0% | −5,129 |
| Aqr Capital Management LLC | 433,132 | $2.0M | 0.0% | +276,906 |
| Millennium Management LLC | 411,870 | $1.9M | 0.0% | New |
| Diametric Capital, LP | 331,423 | $1.5M | 0.2% | +218,320 |
| Commonwealth Equity Services, LLC | 307,347 | $1.4M | 0.0% | +1 |
| Empowered Funds, LLC | 306,085 | $1.4M | 0.0% | −5,129 |
| Morgan Stanley | 304,666 | $1.4M | 0.0% | +25,056 |
| Bank of New York Mellon Corp | 268,653 | $1.2M | 0.0% | +61,623 |
| Hartree Partners, LP | 260,000 | $1.2M | 0.3% | No change |
| Jane Street Group, LLC | 258,722 | $1.2M | 0.0% | −23,034 |
| American Century Companies Inc | 257,715 | $1.2M | 0.0% | −304,826 |
| Marshall Wace, Llp | 232,306 | $1.1M | 0.0% | −152,593 |
| Nuveen, LLC | 208,320 | $941.6K | 0.0% | +107,362 |
| Northern Trust Corp | 206,933 | $935.3K | 0.0% | −4,566 |
| Tudor Investment Corp Et Al | 197,564 | $893.0K | 0.0% | New |
| Vanguard Portfolio Management LLC | 176,188 | $796.4K | 0.0% | +31,194 |
13F reports cover disclosed long positions in U.S. stocks only.
The numbers on this page point here. Each one links to the record it came from.